Cure My Disease

Don't miss your cure!

 Log in / Sign up

Breakfast shake may tame blood sugar spikes in overweight adults

NCT ID NCT06856460

Disease control Sponsor: Arizona State University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether replacing breakfast with a low glycemic index shake helps overweight and obese adults manage their blood sugar. 46 non-diabetic adults aged 25-65 with a BMI between 25 and 40 took part. For two weeks, they either drank the shake or ate oat cereal for breakfast, and researchers measured their glucose and insulin responses. The goal was to see if the shake leads to better blood sugar control compared to a standard breakfast.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

46 people

The number who actually took part.

Started

Mar 2025

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Body mass index 25-40 * Eating pattern 3 meals a day * stable weight for the last 2 months (\<5 pounds fluctuation) * Willing to eat oat cereal for breakfast * glycated hemoglobin \<7% Exclusion Criteria: * glycated hemoglobin \>7% * Body mass index ≤25 or ≥ 40 * Night shifting work * Atypical meal pattern (not three meals a day or intermittent fasting) * Thyroid medication * Bariatric surgery * Habitual strenuous exercise * Commuting by bicycle * Eating disorders * Use of aspirin during the duration of the study * Intake of Vit C \>60 mg/day during the study * cancer * cardiovascular disease * renal disease * hepatic disease * X-ray, MRI or CT appointment during the study duration * Current infection requiring medication * Chronic, contagious, infectious diseases such as tuberculosis, Hepatitis A, B, C, or HIV * Medications of supplements that could affect body weight or appetite (i.e. Ozempic) * Participating in another study at the same time

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hyperglycemia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperglycemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hyperglycemia Obesity prevention

Contacts and locations

Locations

  • Arizona State University 850 PBC

    Phoenix, Arizona, 85004, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.